The Power of Social Network Interventions on Population Health

Published May 23, 2017
Dr. Nicholas Christakis Presented Research on How Social Contagion Interventions Could Impact Health Care   Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session this morning at its 22nd Annual International Meeting in Boston, MA, USA. The plenary, Social Network Interventions and Population Health, highlighted the research of Nicholas A. Christakis, MD, PhD, MPH, Sol Goldman Professor, Social and Natural Science, Co-Director, Yale Institute for Network Science, Yale University, New Haven, CT, USA. The plenary was moderated by Shelby D. Reed, PhD, RPh, Professor, Duke University, Durham, NC, USA and ISPOR President-Elect.   Dr. Christakis provided an overview of his 20-years of research on social networks. His research includes the application of social network principles in order to change population-level behaviors in a variety of arenas, including health. Social network interventions could be used in a variety of areas in health care such as obesity, smoking cessation, pathogens, and medication choice. He noted that human beings have been embedding themselves in real social networks for thousands of years. His early research examined obesity and social contagion, showing that clustering occurs and that information, disease, and emotion spreads to three-degrees of separation (e.g., revealing that your weight [whether you lose or gain weight] will actually affect the weight of your friends and your friends’ friends). His other research focused on the impact of human emotions in the context of social networks, which found that emotions are also effected by social networks (e.g., happiness and anger also spread through social networks to three-degrees of separation). Through his research exploring altruism, Dr. Christakis found that the concept of “paying it forward” is real and spreads across people and across time. An important concept that has emerged from this research is that a network functions like a “social magnifying glass.” When these networks are “seeded” with specific behaviors or emotions (e.g., healthy or unhealthy behaviors, emotions, etc.), the information is spread and amplified throughout the network to transform the natural world. Additionally, research indicates that there is heritability of our network position, meaning it is literally “in our genes” that determines the people with whom we form these networks. Additional information on Dr. Christakis’ work can be found here. Information on his most recent article published last week in Nature can be found here. Information on the ISPOR 22nd Annual International Meeting can be found here. Released presentations from the conference can be found here. Interested parties can follow conference news at ISPOR’s press site and on social media using the conference hashtag #ISPORBoston.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×